A novel source of methylglyoxal and glyoxal in Retina: Implications for age-related macular degeneration

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Yoon, Kee Dong ^a   Yamamoto, Kazunori ^a   Ueda, Keiko ^a   Zhou, Jilin ^a   Sparrow, Janet R ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A2E; ADVANCED GLYCATION END PRODUCT; ALDEHYDE DERIVATIVE; ALL TRANS RETINAL DIMER; AMINOGUANIDINE; BISRETINOID; CHEMICAL COMPOUND; DICARBONYL GLYOXAL; FLUOROPHORE; GLYOXAL; GLYOXAL DERIVATIVE; LIPOFUSCIN; METHYLGLYOXAL; OXO ALDEHYDE; PIGMENT; RETINOID DERIVATIVE; UNCLASSIFIED DRUG;

AGING; ARTICLE; ATHEROSCLEROSIS; CHRONIC DISEASE; DIABETES MELLITUS; DRUSEN; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCATION; HUMAN; HUMAN CELL; LIGHT; OXIDATION; PHOTODEGRADATION; PHOTOOXIDATION; PIGMENT EPITHELIUM; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; RETINA MACULA DEGENERATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; GUANIDINES; HUMANS; LIPOFUSCIN; MACULAR DEGENERATION; PHENYLHYDRAZINES; PYRIDINIUM COMPOUNDS; PYRUVALDEHYDE; RETINA; RETINAL DRUSEN; RETINALDEHYDE; RETINOIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84864063972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041309     Document Type: Article

References (47)

1. Sparrow JR, Wu Y, Kim CY, Zhou J, (2010) Phospholipid meets all-trans-retinal: the making of RPE bisretinoids. J Lipid Res 51: 247-261.
2. Curcio CA, Johnson M, Huang JD, Rudolf M, (2009) Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res 28: 393-422.
3. Hussain AA, Starita C, Hodgetts A, Marshall J, (2010) Macromolecular diffusion characteristics of ageing human Bruch's membrane: implications for age-related macular degeneration (AMD). Exp Eye Res 90: 703-710.
4. Chong NH, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, et al. (2005) Decreased Thickness and Integrity of the Macular Elastic Layer of Bruch's Membrane Correspond to the Distribution of Lesions Associated with Age-Related Macular Degeneration. Am J Pathol 166: 241-251.
5. Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen AA, (2010) The dynamic nature of Bruch's membrane. Prog Retin Eye Res 29: 1-18.
6. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY,et al. (2005) A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 123: 1570-1574.
7. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT,et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29: 95-112.
8. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
9. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
10. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
11. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
12. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
13. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
14. Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, et al. (1999) Increase in advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci 40: 775-779.
15. Farboud B, Aotaki-Keen A, Miyata T, Hjelmeland LM, Handa JT, (1999) Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye. Mol Vision 5: 11.
16. Ishibashi T, Murata T, Hangai M, Nagai R, Horiuchi S, et al. (1998) Advanced glycation end products in age-related macular degeneration. Arch Ophthalmol 116: 1629-1632.
17. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99: 14682-14687.
18. Glenn JV, Beattie JR, Barrett L, Frizzell N, Thorpe SR, et al. (2007) Confocal raman microscopy can quantify advanced glycation end product (AGE) modification in Bruch's membrane leading to accurate nondestructive prediction of ocular aging. FASEB J 21: 3542-3552.
19. Price CL, Knight SC, (2009) Methylglyoxal: possible link between hyperglycaemia and immune suppression? Trends Endocrinol Metab 20: 312-317.
20. Ben-Shabat S, Itagaki Y, Jockusch S, Sparrow JR, Turro NJ, et al. (2002) Formation of a nona-oxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew Chem Int Ed 41: 814-817.
21. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, et al. (2002) Involvement of oxidative mechanisms in blue light induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 43: 1222-1227.
22. Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR, (2010) Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc Natl Acad Sci 107: 7275-7280.
23. Phillips SA, Thornalley PJ, (1993) The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 212: 101-105.
24. Thornalley PJ, Yurek-George A, Argirov OK, (2000) Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem Pharmacol 60: 55-65.
25. Zhou J, Cai B, Jang YP, Pachydaki S, Schmidt AM, et al. (2005) Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res 80: 567-580.
26. Sparrow JR, Parish CA, Hashimoto M, Nakanishi K, (1999) A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 40: 2988-2995.
27. Wolff DJ, Lubeskie A, Li C, (1997) Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cell treated with "irreversible NO synthase inhibitors. Arch Biochem Biophys 338: 73-82.
28. Jang YP, Matsuda H, Itagaki Y, Nakanishi K, Sparrow JR, (2005) Characterization of peroxy-A2E and furan-A2E photooxidation products and detection in human and mouse retinal pigment epithelial cells lipofuscin. J Biol Chem 280: 39732-39739.
29. Yamamoto K, Yoon KD, Ueda K, Hashimoto M, Sparrow JR, (2011) A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine. Invest Ophthalmol Vis Sci 52: 9084-9090.
30. Radu RA, Mata NL, Bagla A, Travis GH, (2004) Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration. Proc Natl Acad Sci U S A 101: 5928-5933.
31. Kim SR, Jang YP, Jockusch S, Fishkin NE, Turro NJ, et al. (2007) The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc Natl Acad Sci U S A 104: 19273-19278.
32. Kim SR, Jang Y, Sparrow JR, (2010) Photooxidation of RPE Lipofuscin bisretinoids enhanced fluorescence intensity. Vision Res 50: 729-736.
33. Wang W, Ballatori N, (1998) Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev 50: 335-355.
34. Dobler D, Ahmed N, Song L, Eboigbodin KE, Thornalley PJ, (2006) Increased dicarbonyl metabolism in endothelial cells in hyperglycemia Induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 55: 1961-1969.
35. Rabbani N, Thornalley PJ, (2008) The dicarbonyl proteome. Proteins susceptible to dicarbonyl glycation at functional sites in health, aging and disease. Ann NY Acad Sci 1126: 124-127.
36. Abordo EA, Minhas HS, Thornalley PJ, (1999) Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem Pharmacol 58: 641-648.
37. Alderson NL, Chachich ME, Frizzell N, Canning P, Metz TO, et al. (2004) Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat. Diabetologia 47: 1385-1395.
38. Roy S, Nasser S, Yee M, Graves DT, Roy S, (2011) A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats. Mol Vis 17: 3166-3174.
39. Rabbani N, Thornalley PJ, (2008) Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans 36: 1045-1050.
40. Ahmed N, Thornalley PJ, (2002) Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J 364: 15-24.
41. Moore DJ, Hussain AA, Marshall J, (1995) Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 36: 1290-1297.
42. Glenn JV, Mahaffy H, Wu K, Smith G, Nagai R, et al. (2009) Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction. Invest Ophthalmol Vis Sci 50: 441-451.
43. Howes KA, Liu Y, Dunaief JL, Milam AH, Frederick JM, et al. (2004) Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 45: 3713-3720.
44. Grey AC, Crouch RK, Koutalos Y, Schey KL, Ablonczy Z, (2011) Spatial localization of A2E in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 52: 3926-3933.
45. Zarbin MA, Rosenfeld PJ, (2010) Pathway-based therapies for age-related macular degeneration. An integrated survey of emerging treatment alternatives. Retina 30: 1350-1367.
46. Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow JR, (1998) Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci U S A 95: 14609-14613.
47. Nawa A, Fujita HW, Tokuyama S, (2010) Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions. LIfe Sci 86: 402-409.